Bile Duct Cancer Research from Dana-Farber Cancer Institute
3 Просмотры
• 06/16/23
0
0
встраивать
administrator
Подписчики
New treatment options are greatly needed in Bile Duct Cancer (cholangiocarcinoma). New research led by Dana-Farber's James Cleary, MD, PhD in Cancer Discovery finds FGFR2 deletion may predict clinical benefit to molecularly targeted therapy. Video published April 30, 2021.
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии